Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: A randomized clinical trial

JAMA Ophthalmology

Volumn 133, Issue 1, 2015, Pages 17-24

  Christen, William G ^a   Glynn, Robert J ^a   Gaziano, J Michael ^a,b   Darke, Amy K ^c   Crowley, John J ^c   Goodman, Phyllis J ^c   Lippman, Scott M ^d   Lad, Thomas E ^e   Bearden, James D ^f   Goodman, Gary E ^g   Minasian, Lori M ^h   Thompson, Ian M ⁱ   Blanke, Charles D ^j   Klein, Eric A ^k  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

^f Gibbs Cancer Center and Research Institute   (United States)

^g SWEDISH MEDICAL CENTER   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ Mays Cancer Center at UT Health San Antonio   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; SELENIUM; ANTIOXIDANT; DRUG COMBINATION; SELENOMETHIONINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CANCER PREVENTION; CATARACT EXTRACTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PUERTO RICO; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SENILE CATARACT; SMOKING; SUPPLEMENTATION; UNITED STATES; VISUAL ACUITY; AGED; AGING; BIOASSAY; CATARACT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; AGING; ANTIOXIDANTS; CATARACT; CATARACT EXTRACTION; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENDPOINT DETERMINATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK FACTORS; SELENOMETHIONINE; SURVEYS AND QUESTIONNAIRES; VITAMIN E;

EID: 84920971126     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.3478     Document Type: Article

References (40)

1. Gerster H. Antioxidant vitamins in cataract prevention. Z Ernahrungswiss. 1989;28(1):56-75.
2. Bunce GE, Kinoshita J, Horwitz J. Nutritional factors in cataract. Annu Rev Nutr. 1990;10:233-254.
3. Varma SD, Devamanoharan PS, Morris SM. Prevention of cataracts by nutritional and metabolic antioxidants. Crit Rev Food Sci Nutr. 1995; 35(1-2):111-129.
4. Rasi V, Costantini S, Moramarco A, Giordano R, Giustolisi R, Balacco Gabrieli C. Inorganic element concentrations in cataractous human lenses. Ann Ophthalmol. 1992;24(12):459-464.
5. Yeum KJ, Shang FM, Schalch WM, Russell RM, Taylor A. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr Eye Res. 1999;19(6):502-505.
6. Varma SD, Beachy NA, Richards RD. Photoperoxidation of lens lipids: prevention by vitamin E. Photochem Photobiol. 1982;36(6): 623-626.
7. Libondi T, Menzione M, Auricchio G. In vitro effect of alpha-tocopherol on lysophosphatidylcholine-induced lens damage. Exp Eye Res. 1985;40(5):661-666.
8. Karslioglu I, Ertekin MV, Koc¸er I, et al. Protective role of intramuscularly administered vitamin E on the levels of lipid peroxidation and the activities of antioxidant enzymes in the lens of rats made cataractous with gamma-irradiation. Eur J Ophthalmol. 2004;14(6):478-485.
9. Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther. 2000;16(2):121-135.
10. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006;6(1):1-19.
11. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci. 2000;57(13-14):1825-1835.
12. Patching SG, Gardiner PH. Recent developments in selenium metabolism and chemical speciation: a review. J Trace Elem Med Biol. 1999;13(4):193-214.
13. Alfthan G, Aro A, Arvilommi H, Huttunen JK. Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate. Am J Clin Nutr. 1991;53(1):120-125.
14. Nève J. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol. 1995;9(2):65-73.
15. Levander OA, Alfthan G, Arvilommi H, et al. Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr. 1983; 37(6):887-897.
16. Zhu X, Guo K, Lu Y. Selenium effectively inhibits 1,2-dihydroxynaphthalene-induced apoptosis in human lens epithelial cells through activation of PI3-K/Akt pathway. Mol Vis. 2011;17:2019-2027.
17. Knekt P, Heliövaara M, Rissanen A, Aromaa A, Aaran RK. Serum antioxidant vitamins and risk of cataract. BMJ. 1992;305(6866):1392-1394.
18. Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol. 1988;106(3): 337-340.
19. Jacques PF, Hartz SC, Chylack LT Jr, McGandy RB, Sadowski JA. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am J Clin Nutr. 1988;48(1):152-158.
20. Chiu CJ, Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res. 2007;84(2):229-245.
21. Karaküc¸ük S, Ertugrul Mirza G, Faruk Ekinciler O, Saraymen R, Karaküc¸ük I, Ustdal M. Selenium concentrations in serum, lens and aqueous humour of patients with senile cataract. Acta Ophthalmol Scand. 1995;73(4):329-332.
22. Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. J Epidemiol Community Health. 1998;52(7):468-472.
23. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies: two nutrition intervention trials. Arch Ophthalmol. 1993;111(9):1246-1253.
24. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS reportNo. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
25. Chylack LT Jr, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 2002;9(1):49-80.
26. McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology. 2004;111(1):75-84.
27. Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology. 2008;115(5):822-829, e1.
28. Christen WG, Glynn RJ, Sesso HD, et al. Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol. 2010; 128(11):1397-1405.
29. Maraini G, Williams SL, Sperduto RD, et al; Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities: clinical trial of nutritional supplements and age-related cataract reportNo. 3. Ophthalmology. 2008;115(4):599-607, e1.
30. Christen WG, Glynn RJ, Manson JE, et al. Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2014;121 (2):525-534.
31. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301 (1):39-51.
32. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005; 97(2):94-102.
33. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556.
34. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr. 1991;53(4) (suppl):1050S-1055S.
35. Chow CK, Reddy K, Tappel AL. Effect of dietary vitamin E on the activities of the glutathione peroxidase system in rat tissues. J Nutr. 1973;103 (4):618-624.
36. Costagliola C, Menzione M. Effect of vitamin E on the oxidative state of glutathione in plasma. Clin Physiol Biochem. 1990;8(3):140-143.
37. Reed DJ. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol. 1990;30: 603-631.
38. Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J AmDiet Assoc. 2000; 100(6):637-640.
39. Mares-Perlman JA, Brady WE, Klein BE, et al. Diet and nuclear lens opacities. Am J Epidemiol. 1995;141(4):322-334.
40. Institute of Medicine. Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, and Carotenoids. Washingon, DC: National AcademyPress; 2000.